Last updated on March 2018

Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)

Brief description of study

To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophrenia.

Clinical Study Identifier: TX200785

Contact Investigators or Research Sites near you

Start Over


Meridien Research - Maitland
Maitland, FL USA
  Connect »